Inactive Instrument

Apteryx Imaging Inc.

Equities

XRAY

CA03836P1080

Apteryx Imaging Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019

August 22, 2019 at 05:34 pm EDT

Apteryx Imaging Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was USD 3.933 million compared to USD 3.671 million a year ago. Operating income was USD 248,619 compared to operating loss of USD 237,840 a year ago. Net loss was USD 242,480 compared to net income of USD 378,036 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. For the half year, sales was USD 7.747 million compared to USD 7.003 million a year ago. Operating income was USD 497,915 compared to operating loss of USD 525,482 a year ago. Net loss was USD 856,474 compared to net income of USD 453,400 a year ago. Basic loss per share from continuing operations was USD 0.02 compared to basic earnings per share from continuing operations of USD 0.01 a year ago.

Latest news about Apteryx Imaging Inc.

Apteryx Imaging Inc.(TSXV:XRAY) dropped from S&P/TSX Venture Composite Index	20-08-14	CI
Planet DDS, Inc. completed the acquisition of Apteryx Imaging Inc. from Adam Hirsh and others.	20-08-11	CI
Apteryx Imaging Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-27	CI
Planet DDS, Inc. entered into an arrangement agreement to acquire Apteryx Imaging Inc. for CAD 28 million.	20-05-26	CI
Apteryx Imaging Inc. Enters into Financing Agreement with National Bank of Canada	20-05-04	CI
Apteryx Imaging Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-28	CI
Apteryx Imaging Inc. Auditor Raises 'Going Concern' Doubt	20-04-27	CI
Apteryx Imaging Inc. Provides Update on Development of Artificial Intelligence Solutions for Dental Imaging in Dentistry	20-03-10	CI
Apteryx Imaging Inc. Announces Executive Changes	20-03-03	CI
Apteryx Imaging Inc. Appoints Avi Naider as New Director	20-02-05	CI
Apteryx Imaging Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-25	CI
Apteryx Imaging Inc. Partners with 4th-IR AG to Co-Develop aSuite of Cloud-Based AI Solutions	19-09-18	CI
LED Medical Diagnostics Inc. will Change its Name to Apteryx Imaging Inc	19-09-03	CI
Apteryx Imaging Inc. has Changed its Ticker to XRAY from LMD	19-09-03	CI
Apteryx Imaging Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-22	CI
LED Medical Diagnostics Inc. Announces Board Changes	19-06-20	CI
Led Medical Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-29	CI
Led Medical Diagnostics Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-28	CI
LED Medical Diagnostics Inc. Auditor Raises 'Going Concern' Doubt	19-04-28	CI
LED Medical Diagnostics Inc. Appoints Alexander Ryzhikov to its Board of Directors	19-01-18	CI
LED Medical Diagnostics Inc. Announces Earnings Results for the Three Months and Nine Months Ended September 30, 2018	18-11-28	CI
Apteryx Imaging Inc. announced that it has received CAD 5.478999 million in funding from Ewing Morris & Co. Investment Partners, Polar Asset Management Partners Inc., and other investors	18-09-03	CI
LED Medical Diagnostics Inc. announced that it expects to receive CAD 5.5 million in funding from Ewing Morris & Co. Investment Partners, Polar Asset Management Partners Inc.	18-08-30	CI
LED Medical Diagnostics Inc. Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018	18-08-29	CI
Led Medical Diagnostics Inc. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2018	18-05-24	CI

Chart Apteryx Imaging Inc.

Duration

Period

More charts

Company Profile

Apteryx Imaging Inc., formerly LED Medical Diagnostics Inc., is a dental imaging services and technology company. The Company operates through the development and commercialization of medical devices based on its imaging platform to aid in the detection and treatment of disease in human tissues segment. It also provides dental and oral health specialists with advanced diagnostic imaging products and software. Its portfolio includes its dental imaging products and the VELscope device. It markets a medical device under the trade name VELscope, which is used in the dental industry to help identify oral soft tissue abnormalities, including those which may be cancerous or precancerous and also to help define appropriate margins for surgical excision. The Company also has a digital imaging division, which provides dentists and oral health specialists with diagnostic imaging products and software. It markets, sells, installs and trains RAYSCAN digital imaging technology.

Sector

More about the company